EDGAR Filing Documents for 0001337553-22-000016

Form DEF 14A - Other definitive proxy statements:

SEC Accession No. 0001337553-22-000016

Filing Date

2022-04-26

Accepted

2022-04-26 16:21:52

Documents

Period of Report

2022-06-09

Document Format Files

Seq	Description	Document	Type	Size
1	DEF 14A	aerieproxy2022.htm	DEF 14A	1456388
2		a2021annualbonus442022form.jpg	GRAPHIC	23729
3		a2021peergroupformatted.jpg	GRAPHIC	21256
4		aeriefullcolorhorizontallo.jpg	GRAPHIC	372473
5		aeriefullcolorverticallogo.gif	GRAPHIC	127794
6		aerilogoa02.jpg	GRAPHIC	48344
7		agreement.jpg	GRAPHIC	54162
8		byinternet.jpg	GRAPHIC	49928
9		byml.jpg	GRAPHIC	57161
10		byphone.jpg	GRAPHIC	50158
11		ceo2022trgtpaymix.jpg	GRAPHIC	32013
12		chart-1feb451f96d04cf085c.jpg	GRAPHIC	150414
13		chart-aaea1b3665b84eb7b79.jpg	GRAPHIC	28362
14		chart-ac4ee576bd164461b33.jpg	GRAPHIC	160186
15		charts_pg42-01.jpg	GRAPHIC	166274
16		environmental.jpg	GRAPHIC	56734
17		eyedropper-04.jpg	GRAPHIC	52407
18		governance.jpg	GRAPHIC	57944
19		human.jpg	GRAPHIC	70695
20		inperson.jpg	GRAPHIC	58880
21		jlarocca.jpg	GRAPHIC	9331
22		lti3152022.jpg	GRAPHIC	32890
23		paymix2022442022.jpg	GRAPHIC	43884
24		rkannan.jpg	GRAPHIC	14105
25		social.jpg	GRAPHIC	65387
26		testtube.jpg	GRAPHIC	62443
	Complete submission text file	0001337553-22-000016.txt		3944022

Mailing Address 4301 EMPEROR BOULEVARD SUITE 400 DURHAM NC 27703

Business Address 4301 EMPEROR BOULEVARD SUITE 400 DURHAM NC 27703 (919) 237-5300

AERIE PHARMACEUTICALS INC (Filer) CIK: 0001337553 (see all company filings)